MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with C

Cefradine

Cefradine 250mg capsules

No stability information

Stability notes for Cefradine 250mg capsules

There are no stability notes for this medicine.

Suppliers (6) of Cefradine 250mg capsules
Cefradine 250mg capsules (A A H Pharmaceuticals Ltd)
Cefradine 250mg capsules (Alliance Healthcare (Distribution) Ltd)
Cefradine 250mg capsules (Kent Pharma (UK) Ltd)
Cefradine 250mg capsules (Medihealth (Northern) Ltd)
Cefradine 250mg capsules (Phoenix Healthcare Distribution Ltd)
Cefradine 250mg capsules (Sigma Pharmaceuticals Plc)

Cefradine 500mg capsules

Incompatible

Stability notes for Cefradine 500mg capsules

Very hygroscopic.

Provenance

This compatibility recommendation is derived from Cefradine 500mg capsules (Kent Pharma (UK) Ltd).

Suppliers (6) of Cefradine 500mg capsules
Cefradine 500mg capsules (A A H Pharmaceuticals Ltd)
Cefradine 500mg capsules (Alliance Healthcare (Distribution) Ltd)
Cefradine 500mg capsules (Kent Pharma (UK) Ltd)
Cefradine 500mg capsules (Medihealth (Northern) Ltd)
Cefradine 500mg capsules (Phoenix Healthcare Distribution Ltd)
Cefradine 500mg capsules (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.